Bookmark
Forward
Explore Literature Results
Explore Clinical Trials Results
QuickView for disease-modifying antirheumatic drug (compound)
Most Relevant Literature
- Higher infection risk for JAK inhibitors tofacitinib and baricitinib compared to subcutaneous biolog…
- Apical fibrobullous lung disease in spondyloarthritis patients with biologic DMARDs indication.
- Comparative effectiveness of baricitinib and alternative biological DMARDs in a Swiss cohort study o…
- Effect of DMARDs on the immunogenicity of vaccines.
- Reasons for multiple biologic and targeted synthetic DMARD switching and characteristics of treatmen…
Most Relevant Clinical Trials
- Open-Label Study Comparing Etanercept to Conventional Disease Modifying Antirheumatic Drug (DMARD) T…
- A Study of JNJ-40346527 in Patients With Active Rheumatoid Arthritis Despite Disease-modifying Antir…
- EMBRACE-SC: Observational Study of Subcutaneous (SC) Tocilizumab Alone or in Combination With Conven…
- Study to Evaluate the Efficacy and Safety of Filgotinib in Participants With Active Ankylosing Spond…
- Study to Evaluate the Efficacy and Safety of Filgotinib in Participants With Active Ankylosing Spond…
